Authors
Latest:
Prioritizing Patients: Strategies and eCOA Best Practices in Drug DevelopmentA more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.
Latest:
Changing the Digital Health Playing Field: A New EraMoving beyond the pill to extend the value being delivered to patients.
Latest:
Navigating the Intersection of Accessibility and Measurement Integrity in eCOAClinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data capture for inclusive clinical trials.
Latest:
Increased Digitization in Clinical Trials: Expectations for the Year AheadTop predictions for the major trends that will shape clinical trial design in 2022.
Latest:
Tapping the Patient Voice as a Strategic DifferentiatorThe future of clinical trial design involves incorporating the patient experience into strategic asset planning.
Latest:
Early Protocol Assessment for Increased Patient CentricityHow novel clinical trial designs can help minimize patient burden.
Latest:
The Value of Clinical Trial Liaisons in the Drug Development LifecycleClinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.
Latest:
Harnessing Unstructured Data and Hospital InteroperabilityThe potential of next-generation platforms in transforming patient recruitment.
Latest:
Compliance Amid the ‘Great Resignation’Minimizing impacts through focus on employee wellness.
Latest:
Four Key Trends for Identifying Regulator and Payer Evidence Needs in Oncology Drug DevelopmentHow to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.
Latest:
Rate of Patient Recruitment to International Multicenter Clinical Studies in Eastern Europe CountriesThe success of a clinical study depends on the possibilities to involve the patient in the study.
Latest:
Digital Measures of Health: What’s in it for Patients?Exploring the different stages in the development of a digital measure, and the activities and steps key to achieving meaningful impact for patients.
Latest:
Getting the Most From FSP ModelExamining best practices in using the functional service provider model for clinical operations, pharmacovigilance, regulatory, and other areas.
Latest:
Getting to Clinical Trial DiversityDiffering levels of trust in clinical trials information channels across diverse populations is examined in this research.
Latest:
How to Determine ‘Good Science’ for Systematic Literature Reviews in Clinical Research and DevelopmentBest practices for assessing publications.
Latest:
Currency of Patient Engagement: Changing TidesMeeting patients at the point of care can increase trust and engagement.
Latest:
Identify Opportunities to Improve Diversity RecruitmentWhile it's important to note that there are areas where the industry can improve, there are unique opportunities of improvement for specific types of sites and the number of studies conducted there.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Engaging Patients With Behavioral Science and Patient-centered TechnologyEvolving mindsets are opening the door for industry to utilize new mediums for understanding patients.
Latest:
The Future Fit of Wearables for Patient-Centric Clinical TrialsHarnessing these tools for successful integration and streamlining of processes.
Latest:
Clinical Trials as a Competitive Edge: Strategic ConsiderationsNavigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.
Latest:
The Current Status of European Research Related to COVID-19: The EUCROF PerspectiveSuccessful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
Latest:
Establishing Metrics and Standardization for Non-CRF Data in EDCWhile Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
Latest:
How Digital Will Transform Product Development in 2022 and BeyondPandemic sparks new long-term plan for success in R&D.
Latest:
Evolving Toward Empowerment: How We Are Deepening Relationships With PatientsMultilayered strategies such as working with patient advocacy organizations and leveraging technology can help industry better partner with patients.
